Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2012

Open Access 01-12-2012 | Research

Development of the multi-attribute Adolescent Health Utility Measure (AHUM)

Authors: Kathleen M Beusterien, Jean-Ezra Yeung, Francis Pang, John Brazier

Published in: Health and Quality of Life Outcomes | Issue 1/2012

Login to get access

Abstract

Objective

Obtain utilities (preferences) for a generalizable set of health states experienced by older children and adolescents who receive therapy for chronic health conditions.

Methods

A health state classification system, the Adolescent Health Utility Measure (AHUM), was developed based on generic health status measures and input from children with Hunter syndrome and their caregivers. The AHUM contains six dimensions with 4–7 severity levels: self-care, pain, mobility, strenuous activities, self-image, and health perceptions. Using the time trade off (TTO) approach, a UK population sample provided utilities for 62 of 16,800 AHUM states. A mixed effects model was used to estimate utilities for the AHUM states. The AHUM was applied to trial NCT00069641 of idursulfase for Hunter syndrome and its extension (NCT00630747).

Results

Observations (i.e., utilities) totaled 3,744 (12*312 participants), with between 43 to 60 for each health state except for the best and worst states which had 312 observations. The mean utilities for the best and worst AHUM states were 0.99 and 0.41, respectively. The random effects model was statistically significant (p < 0.0001; adjusted R2 = 0.361; RMSE = 0.194). When AHUM utilities were applied to the idursulfase trial, mean utilities in the idursulfase weekly and placebo groups improved +0.087 and +0.006, respectively, from baseline to week 53. In the extension, when all patients received idursulfase, the utilities in the treatment group remained stable and the placebo group improved +0.039.

Discussion

The AHUM health state classification system may be used in future research to enable calculation of quality-adjust life expectancy for applicable health conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brazier JE, Ratcliffe J, Tsuchiya A, Solomon J: Measuring and valuing health for economic evaluation. Oxford University Press, Oxford; 2007. Brazier JE, Ratcliffe J, Tsuchiya A, Solomon J: Measuring and valuing health for economic evaluation. Oxford University Press, Oxford; 2007.
2.
go back to reference Griebsch I, Coast J, Brown J: Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health. Pediatrics 2005, 115(5):600–614. 10.1542/peds.2004-2127CrossRef Griebsch I, Coast J, Brown J: Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health. Pediatrics 2005, 115(5):600–614. 10.1542/peds.2004-2127CrossRef
3.
go back to reference Drummond MF, Iglesias CP, Cooper NJ: Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: a game of two halves? Int J Technol Assess Health Care. 2008, 24(2):146–50.CrossRefPubMed Drummond MF, Iglesias CP, Cooper NJ: Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: a game of two halves? Int J Technol Assess Health Care. 2008, 24(2):146–50.CrossRefPubMed
4.
go back to reference Gold MR, Siegal JE, Russell LB, Weinstein MC: Cost-effectiveness in Health and Medicine. Oxford University Press, New York; 1996. Gold MR, Siegal JE, Russell LB, Weinstein MC: Cost-effectiveness in Health and Medicine. Oxford University Press, New York; 1996.
5.
go back to reference NICE: National Institute for Clinical Excellence Guide to Methods of Technology Appraisal. National Institute for Clinical Excellence, London, England; 2004. NICE: National Institute for Clinical Excellence Guide to Methods of Technology Appraisal. National Institute for Clinical Excellence, London, England; 2004.
6.
go back to reference Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 2002, 21(2):271–292. 10.1016/S0167-6296(01)00130-8CrossRefPubMed Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 2002, 21(2):271–292. 10.1016/S0167-6296(01)00130-8CrossRefPubMed
7.
go back to reference Dolan P: Modelling valuations for EuroQol health states. Medical Care 1997, 35(11):1095–1108. 10.1097/00005650-199711000-00002CrossRefPubMed Dolan P: Modelling valuations for EuroQol health states. Medical Care 1997, 35(11):1095–1108. 10.1097/00005650-199711000-00002CrossRefPubMed
8.
go back to reference Norrby U, Nordholm L, Andersson-Gare BA, Fasth A: Health-related quality of life in children diagnosed with asthma, diabetes, juvenile chronic arthritis, or short stature. Acta Paediatrica 2006, 95: 450–56. 10.1080/08035250500437499CrossRefPubMed Norrby U, Nordholm L, Andersson-Gare BA, Fasth A: Health-related quality of life in children diagnosed with asthma, diabetes, juvenile chronic arthritis, or short stature. Acta Paediatrica 2006, 95: 450–56. 10.1080/08035250500437499CrossRefPubMed
9.
go back to reference Visser-van Balen H, Geenen R, Moerbeek M, et al.: Psychosocial functioning of adolescents with idiopathic short stature or persistent short stature born small for gestational age during three years of combined growth hormone and gonadotropin-releasing hormone agonist treatment. Horm Res 2005, 64: 77–87. 10.1159/000087700CrossRefPubMed Visser-van Balen H, Geenen R, Moerbeek M, et al.: Psychosocial functioning of adolescents with idiopathic short stature or persistent short stature born small for gestational age during three years of combined growth hormone and gonadotropin-releasing hormone agonist treatment. Horm Res 2005, 64: 77–87. 10.1159/000087700CrossRefPubMed
10.
go back to reference Gutierrez-Solana LG: Clinical study of enzyme replacement therapy with dursulfase. Rev Neurol 2007, 44(1):S7-S11.PubMed Gutierrez-Solana LG: Clinical study of enzyme replacement therapy with dursulfase. Rev Neurol 2007, 44(1):S7-S11.PubMed
11.
go back to reference Landgraf JM, Maunsell E, Speechley KN, Bullinger M, Campbell S, Abetz L, Ware JE: Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results. Qual Life Res 1998, 7(5):433–45.CrossRefPubMed Landgraf JM, Maunsell E, Speechley KN, Bullinger M, Campbell S, Abetz L, Ware JE: Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results. Qual Life Res 1998, 7(5):433–45.CrossRefPubMed
12.
go back to reference Rosenberg M: Society and the Adolescent Self-Image. Revised edition. Wesleyan University Press, Middletown, CT; 1989. Rosenberg M: Society and the Adolescent Self-Image. Revised edition. Wesleyan University Press, Middletown, CT; 1989.
13.
go back to reference Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): Conceptual framework and item selection. Med Care 1992, 30(6):473–83. 10.1097/00005650-199206000-00002CrossRefPubMed Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): Conceptual framework and item selection. Med Care 1992, 30(6):473–83. 10.1097/00005650-199206000-00002CrossRefPubMed
15.
go back to reference Torrance GW: Measurement of health state utilities for economic appraisal. Journal Health Economics 1986, 5: 1–30. 10.1016/0167-6296(86)90020-2CrossRef Torrance GW: Measurement of health state utilities for economic appraisal. Journal Health Economics 1986, 5: 1–30. 10.1016/0167-6296(86)90020-2CrossRef
16.
go back to reference Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT, Velikova G: Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value in Health 2011, 14(5):721–731. 10.1016/j.jval.2011.01.004CrossRefPubMed Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT, Velikova G: Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value in Health 2011, 14(5):721–731. 10.1016/j.jval.2011.01.004CrossRefPubMed
17.
go back to reference Yang Y, Brazier J, Tsuchiya A, Young T: Estimating a preference-based index for a 5-dimensional health state classification for asthma (AQL-5D) derived from the Asthma Quality of Life Questionnaire (AQLQ). Medical Decision Making 2011, 31(2):281–291. 10.1177/0272989X10379646CrossRefPubMed Yang Y, Brazier J, Tsuchiya A, Young T: Estimating a preference-based index for a 5-dimensional health state classification for asthma (AQL-5D) derived from the Asthma Quality of Life Questionnaire (AQLQ). Medical Decision Making 2011, 31(2):281–291. 10.1177/0272989X10379646CrossRefPubMed
18.
go back to reference Muenzer J, Wraith JE, et al.: A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 2006, 8(8):465–73. 10.1097/01.gim.0000232477.37660.fbCrossRefPubMed Muenzer J, Wraith JE, et al.: A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 2006, 8(8):465–73. 10.1097/01.gim.0000232477.37660.fbCrossRefPubMed
19.
go back to reference Muenzer J, Beck M, Eng CM, Giugliani R, Harmatz P, Martin R, et al.: Long-term, open-labeled extension study of idursulfase in the treatment of Hunter Syndrome. Genet Med 2011, 13(2):95–101. 10.1097/GIM.0b013e3181fea459CrossRefPubMed Muenzer J, Beck M, Eng CM, Giugliani R, Harmatz P, Martin R, et al.: Long-term, open-labeled extension study of idursulfase in the treatment of Hunter Syndrome. Genet Med 2011, 13(2):95–101. 10.1097/GIM.0b013e3181fea459CrossRefPubMed
21.
go back to reference Beusterien KM, Davies J, Leach M, Meiklejohn D, Grinspan J, O’Toole A, Bramham-Jones S: Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study. Health and Quality of Life Outcomes 2010, 8: 50. 10.1186/1477-7525-8-50PubMedCentralCrossRefPubMed Beusterien KM, Davies J, Leach M, Meiklejohn D, Grinspan J, O’Toole A, Bramham-Jones S: Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study. Health and Quality of Life Outcomes 2010, 8: 50. 10.1186/1477-7525-8-50PubMedCentralCrossRefPubMed
22.
go back to reference Beusterien KM, Szabo SM, Kotapati S, Mukherjee J, Hoos A, Hersey P, Middleton MR, Levy AR: Societal preference values for advanced melanoma health states in the United Kingdom and Australia. Br J Cancer 2009, 101(3):387–9. 10.1038/sj.bjc.6605187PubMedCentralCrossRefPubMed Beusterien KM, Szabo SM, Kotapati S, Mukherjee J, Hoos A, Hersey P, Middleton MR, Levy AR: Societal preference values for advanced melanoma health states in the United Kingdom and Australia. Br J Cancer 2009, 101(3):387–9. 10.1038/sj.bjc.6605187PubMedCentralCrossRefPubMed
23.
go back to reference Kuratsubo I, Suzuki Y, Orii KO: Psychological status of patients with mucopolysaccharidosis type II and their parents. Pediatrics International 2009, 51: 41–47. 10.1111/j.1442-200X.2008.02652.xCrossRefPubMed Kuratsubo I, Suzuki Y, Orii KO: Psychological status of patients with mucopolysaccharidosis type II and their parents. Pediatrics International 2009, 51: 41–47. 10.1111/j.1442-200X.2008.02652.xCrossRefPubMed
24.
go back to reference Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA: Measuring preferences for health states worse than death. Medical Decision Making 1994, 14: 8–18.CrossRef Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA: Measuring preferences for health states worse than death. Medical Decision Making 1994, 14: 8–18.CrossRef
25.
go back to reference Wee HL, Machin D, Loke WC, et al.: Assessing Differences in Utility Scores:A Comparison of Four Widely Used Preference-Based Instruments. Value in Health 2007, 10(4):257–65.CrossRef Wee HL, Machin D, Loke WC, et al.: Assessing Differences in Utility Scores:A Comparison of Four Widely Used Preference-Based Instruments. Value in Health 2007, 10(4):257–65.CrossRef
Metadata
Title
Development of the multi-attribute Adolescent Health Utility Measure (AHUM)
Authors
Kathleen M Beusterien
Jean-Ezra Yeung
Francis Pang
John Brazier
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2012
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-10-102

Other articles of this Issue 1/2012

Health and Quality of Life Outcomes 1/2012 Go to the issue